Intra-cellular therapies, inc. (ITCI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows used in operating activities
Net loss

-160,297

-147,722

-147,887

-154,547

-154,483

-155,127

-144,588

-125,935

-106,319

-97,773

-95,049

-102,444

-115,518

-116,426

-117,775

-119,670

-110,347

-104,793

-91,157

-65,412

-48,435

-30,691

-23,533

-30,295

-25,773

-26,868

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

524

477

430

396

387

368

331

290

245

213

205

201

199

196

193

189

172

139

98

59

34

25

26

24

23

23

0

0

0

Share-based compensation

21,237

20,788

19,274

18,840

18,164

17,396

16,582

14,709

14,767

14,641

14,755

15,941

15,269

14,701

14,400

13,579

12,383

10,890

9,117

7,954

5,743

3,843

2,301

718

517

391

0

0

0

Stock issued for services

199

194

194

194

193

192

191

190

190

190

205

220

235

233

216

199

182

182

0

0

0

-

-

-

-

-

-

-

-

Amortization of premiums and discounts on investment securities, net

1,073

1,131

1,269

1,355

1,243

943

515

119

-231

-429

-525

-540

-503

-544

-612

-686

-743

-712

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable, net

0

-

-

-

-

-

-

-

-

-94

5

-36

68

63

1

89

-3

-20

-124

-210

-164

-284

-126

-56

-63

35

0

0

0

Inventory

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-428

-1,465

-3,377

-2,725

2,287

3,026

1,961

-245

2,388

879

1,283

2,124

-3,024

-4,016

2,494

-4,587

5,523

6,737

159

8,119

552

466

508

330

507

574

0

0

0

Long term deferred tax asset, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Professional fees paid by related party on behalf of the Company

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Accounts payable

2,419

-6,536

-4,222

253

-1,464

7,787

6,045

3,603

2,881

2,418

-1,009

-2,114

5,198

2,121

4,712

-1,021

-2,615

-419

201

4,495

2,431

-1,342

-3,523

-2,990

-1,260

3,353

0

0

0

Accrued liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Accrued liabilities and other

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,666

0

0

0

Deferred rent

-

-

-

-

-

267

-80

-69

-59

18

348

678

991

1,271

1,682

1,738

1,810

1,597

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-88,005

-

-97,862

-88,716

-106,221

-102,279

-73,430

-57,340

-31,533

-22,807

-25,228

-25,571

-27,282

-22,591

0

0

0

Net cash used in operating activities

-143,580

-127,983

-122,088

-120,509

-126,814

-118,169

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Cash flows (used in) provided by investing activities
Purchases of investments

276,859

80,720

88,374

113,277

193,614

271,156

487,366

498,549

510,852

520,926

350,333

419,562

465,057

395,757

603,260

602,866

475,809

514,308

0

0

0

-

-

-

-

-

-

-

-

Maturities of investments

257,224

258,857

243,630

256,355

309,882

406,189

456,826

476,995

491,271

428,932

411,384

496,326

538,956

488,068

442,993

344,145

190,646

153,389

0

0

0

-

-

-

-

1,500

0

0

0

Purchases of property and equipment

655

700

1,409

1,204

163

391

848

936

990

723

207

112

73

48

85

185

344

860

827

718

529

11

8

32

31

33

0

0

0

Net cash (used in) provided by investing activities

-20,289

177,436

153,846

141,873

116,105

134,641

-31,389

-22,490

-20,570

-92,717

60,843

76,651

73,824

92,262

-160,352

-258,906

-285,506

-361,779

-112,289

-84,539

-133,435

-66,734

-65,286

-47,477

-73

1,466

0

0

0

Cash flows provided by financing activities
Proceeds from exercise of stock options

3,793

3,235

628

620

367

674

542

398

398

285

258

360

538

477

785

740

715

653

0

0

0

-

-

-

-

-

-

-

-

Increase in note payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Proceeds of public offering, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

449,996

449,996

122,083

122,083

116,191

116,191

0

0

-

-

0

-

Payment of costs of public offerings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

756

745

278

303

748

0

0

0

-

-

-

-

Net cash provided by financing activities

280,771

3,235

628

631

378

685

162,625

162,470

162,471

162,357

-124,741

360

538

477

125,774

328,176

328,166

449,893

449,633

122,157

122,153

115,715

115,657

0

0

-

-

0

-

Net increase in cash, cash equivalents, and restricted cash

116,901

52,689

32,386

21,996

-10,330

17,157

17,436

40,176

50,823

-10,852

-148,047

-22,382

-13,642

1,482

-132,440

-19,445

-63,561

-14,165

263,912

-19,721

-42,816

26,174

24,843

76,253

128,727

19,505

0

0

0

Non-cash investing and financing activities
Right of use assets under operating leases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

0

0

0

-

-

-

-

Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Professional fees paid by related party on behalf of the Company

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-